Skip to main content

Altitude Crest Partners Inc.

SEC CIK
0001986035
Latest filing
Feb 14, 2025

ENGN holding history

enGene Therapeutics Inc. in every 13F filed by Altitude Crest Partners Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ENGN overviewAll 13F holders of ENGNFull Q4 2024 holdings

Shares (Q2 2024)
0
Sold out in Q2 2024
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q1 2024
Holdings of ENGN by Altitude Crest Partners Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20240$00.0%−120,289−100.0%Sold outHolders
Q1 2024120,289$2.04M0.9%+120,289NewHolders